Analysts Set Expectations for TerrAscend Q1 Earnings

TerrAscend Corp. (OTCMKTS:TSNDF) – Analysts at Seaport Res Ptn issued their Q1 2026 earnings per share (EPS) estimates for shares of TerrAscend in a research report issued to clients and investors on Sunday, March 9th. Seaport Res Ptn analyst S. Randhawa anticipates that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share. Seaport Res Ptn also issued estimates for TerrAscend’s Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.03) EPS and Q4 2026 earnings at ($0.03) EPS.

TerrAscend (OTCMKTS:TSNDF) last released its earnings results on Thursday, March 6th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.04. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. The business had revenue of $74.35 million for the quarter, compared to the consensus estimate of $72.37 million.

Separately, Atb Cap Markets cut shares of TerrAscend from a “strong-buy” rating to a “hold” rating in a report on Monday, December 9th.

TerrAscend Stock Performance

Shares of TSNDF stock opened at $0.45 on Tuesday. The company has a market capitalization of $131.90 million, a price-to-earnings ratio of -1.61 and a beta of 1.64. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35. TerrAscend has a one year low of $0.38 and a one year high of $2.20. The company’s 50-day moving average is $0.57 and its 200 day moving average is $0.85.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.